Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. G 137
2. G-137
1. 32828-81-2
2. 4-methoxy-n,n'-bis(3-pyridinylmethyl)-1,3-benzenedicarboxamide
3. 4-methoxy-1-n,3-n-bis(pyridin-3-ylmethyl)benzene-1,3-dicarboxamide
4. G-137
5. Nsc-304384
6. 654g2vci4q
7. Einecs 251-245-7
8. Picotamide [inn:ban]
9. Brn 0499268
10. Unii-654g2vci4q
11. 4-methoxy-n,n'-bis(3-pyridylmethyl)isophthaldiamide
12. Sr-01000076086
13. G 137
14. N,n'-bis(3-picolyl)-4-methoxyisophthalamide
15. Plactidil (tn)
16. 4-methoxy-n,n'-bis(3-pyridylmethyl)isophthalamide
17. Picotamide (ban)
18. Isophthalamide, 4-methoxy-n,n'-bis(3-pyridylmethyl)-
19. Picotamide [mi]
20. N,n'-bis(3-pyridinylmethyl)-4-methoxy-1,3-benzenedicarboxamide
21. Prestwick0_000119
22. Prestwick1_000119
23. Prestwick2_000119
24. Prestwick3_000119
25. Lopac-p-8477
26. Picotamide [mart.]
27. Picotamide [who-dd]
28. Lopac0_001003
29. Bspbio_000138
30. N,n'-bis(3-pyridylmethyl)-4-methoxyisophthalamide
31. Schembl137025
32. Spbio_002077
33. Bpbio1_000152
34. Chembl1257015
35. Chebi:93175
36. Gtpl11379
37. Dtxsid40186498
38. Hms2090l18
39. Hms3263i07
40. Zinc538174
41. Tox21_501003
42. 1,3-benzenedicarboxamide, N,n'-bis(3-pyridinylmethyl)-4-methoxy-
43. Bdbm50103507
44. Nsc304384
45. Ccg-205083
46. Db13327
47. Lp01003
48. Nsc 304384
49. Sdccgsbi-0050976.p003
50. (s)-(-)-2-methoxypropionicacid
51. Ncgc00015847-01
52. Ncgc00015847-02
53. Ncgc00015847-03
54. Ncgc00015847-04
55. Ncgc00015847-05
56. Ncgc00094297-01
57. Ncgc00094297-02
58. Ncgc00261688-01
59. Sbi-0050976.p002
60. Db-048275
61. Eu-0101003
62. Ft-0630565
63. D07140
64. P 8477
65. 828p812
66. L013375
67. J-018896
68. Q1235921
69. Sr-01000076086-1
70. 4-methoxy-n1,n3-bis(pyridin-3-ylmethyl)isophthalamide
71. Brd-k67277431-002-03-0
72. 1,3-benzenedicarboxamide, 4-methoxy-n,n'-bis(3-pyridinylmethyl)-
73. 4-methoxy-n1,n3-bis(3-pyridinylmethyl)benzene-1,3-dicarboxamide
74. 1,3-benzenedicarboxamide, 4-methoxy-n1,n3-bis(3-pyridinylmethyl)-
75. 1085306-93-9
| Molecular Weight | 376.4 g/mol |
|---|---|
| Molecular Formula | C21H20N4O3 |
| XLogP3 | 1.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 7 |
| Exact Mass | 376.15354051 g/mol |
| Monoisotopic Mass | 376.15354051 g/mol |
| Topological Polar Surface Area | 93.2 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 516 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Platelet Aggregation Inhibitors
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)
B - Blood and blood forming organs
B01 - Antithrombotic agents
B01A - Antithrombotic agents
B01AC - Platelet aggregation inhibitors excl. heparin
B01AC03 - Picotamide
Global Sales Information
ABOUT THIS PAGE
70
PharmaCompass offers a list of Picotamide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Picotamide manufacturer or Picotamide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Picotamide manufacturer or Picotamide supplier.
PharmaCompass also assists you with knowing the Picotamide API Price utilized in the formulation of products. Picotamide API Price is not always fixed or binding as the Picotamide Price is obtained through a variety of data sources. The Picotamide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Picotamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Picotamide, including repackagers and relabelers. The FDA regulates Picotamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Picotamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Picotamide supplier is an individual or a company that provides Picotamide active pharmaceutical ingredient (API) or Picotamide finished formulations upon request. The Picotamide suppliers may include Picotamide API manufacturers, exporters, distributors and traders.
Picotamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Picotamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Picotamide GMP manufacturer or Picotamide GMP API supplier for your needs.
A Picotamide CoA (Certificate of Analysis) is a formal document that attests to Picotamide's compliance with Picotamide specifications and serves as a tool for batch-level quality control.
Picotamide CoA mostly includes findings from lab analyses of a specific batch. For each Picotamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Picotamide may be tested according to a variety of international standards, such as European Pharmacopoeia (Picotamide EP), Picotamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Picotamide USP).
